Jiali Chen

Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial

Jing He, Ruijun Zhang, Miao Shao et al. · Annals of the Rheumatic Diseases · 2019 · 337 citations · Full text

Life Sciences, Immunology, Autoimmunity +9

Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome

Jing He, Jiali Chen, Miao Miao et al. · JAMA Network Open · 2022 · 88 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Prevalence and risk factors of diabetic peripheral neuropathy in Type 2 diabetes mellitus patients with overweight/obese in Guangdong province, China

Li Li, Jiali Chen, Jiao Wang et al. · Primary care diabetes · 2014 · 76 citations

Medicine, Neurology, Diabetology +9

Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial

Xiaoying Zhang, Miao Miao, Ruijun Zhang et al. · Signal Transduction and Targeted Therapy · 2022 · 69 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Sphingosine kinase 2 activates autophagy and protects neurons against ischemic injury through interaction with Bcl-2 via its putative BH3 domain

Dandan Song, Tong-Tong Zhang, Jiali Chen et al. · Cell Death and Disease · 2017 · 60 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16